Mexico Cardiologia AHN Uhsr ESCardio Per il cuore WorldHealth ProCOR CIHR CDC WHO Health Canada IHHS G8Cardio
G8Cardio 5th IHHC program speakers Links Members News Search
  You are not logged in Log in Join
You are here: Home » FAMI study pages - FIRB2001

Log in
About
Created by
g8cardio
Document Document
Last modified
2005-09-22
State
published

Fami: Background

FIRST ACUTE MYOCARDIAL INFARCTION (FAMI)

Study of the environmental, inflammatory and genetic causes of myocardial infarction in Italy, China and Scotland

Background

Myocardial infarction (MI) is the single most critical event in coronary disease (CD) because it can precipitate fatal arrhythmias and cardiac failure and it is a major cause of mortality,morbidity and health care expenditure.

MI occurs unheralded as the very first clinical manifestation of CD in over 50% of the cases.

In a substantial percentage of cases the predisposing causes of MI cannot be explained by elevated blood lipids, hypertension, smoking, elevated fibrinogen levels, diabetes, obesity and psychological stress as traditional risk factors account for about 50% of the cases of MI and conversely about 50% of individuals with known risk factors die of non-cardiac causes.

Rapidly growing evidence indicates that inflammation plays a major role in the precipitation of MI and that the prototypic marker of inflammation, C-Reactive Protein (CRP), is a very strongly predictive marker of the future incidence of MI but elevated CRP levels are found only in about 50% of acute MI cases.

In man the incidence of MI increases about 10 times from the age of 40 to 80. In women it is about 10 times lower below the age of 50 and gradually becomes similar to man above 80.

There is a 12 fold difference in the incidence of MI between North European and Oriental countries, with Italy in an intermediate position.

At present the causes of such huge differences in the incidence of MI are only speculative and it remains unknown to what extent the age, sex and population related differences of MI are related to corresponding differences in the prevalence of known risk factors or to yet unknown environmental and genetic predisposing and protective factors. Yet, currently preventive and therapeutic strategies for MI are totally standardised and applied with a "blanket" strategy.

« January 2009 »
Su Mo Tu We Th Fr Sa
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
News
FAMI update
2005-09-22